Search Results 351-360 of 995 for 씨밀레토토

  1. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with ...

  2. A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of BJ-005 in patients with advanced solid tumor or ...

  3. Publications

    Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study. J ...

  4. Publications - Amit Merchea, M.D. - Mayo Clinic

    Cardelli S, Stocchi L, Merchea A, Colibaseanu DT, DeLeon MF, Mishra N, Hancock KJ, Larson DW. Multiple robotic stapler firings to transect the rectum are ...

  6. A Study of Using Geometrically Accurate Functional MRI to Enable Personalized Radiotherapy of Glioblastoma - Mayo Clinic

    The purpose of this study is to create a new Magnetic resonance imaging (MRI) technique with true contrast to the background reference points in functional MR ...

  7. A Trial to Evaluate the Effectiveness, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    The primary purpose of this study is to demonstrate the effectiveness of 1 or 2 dose levels of HZN-825 versus placebo in subjects with diffuse cutaneous ...

  8. Santiago Restrepo Castillo: Developing New Gene Editing Techniques to Cure Disease - Student Research - Mayo Clinic College of Medicine & Science

    Santiago Restrepo Castillo, Ph.D. student in virology and gene therapy at Mayo Clinic, shares research on new gene editing techniques to cure disease.

  9. A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/​or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to determine the safety and tolerability of BMS-986393 in combination with alnuctamab, mezigdomide, ...

  10. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14- ...